NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Feb 20, 2019 $1.89 $1.96 $1.85 $1.88 352 983
Feb 19, 2019 $2.05 $2.07 $1.86 $1.89 952 889
Feb 15, 2019 $2.05 $2.07 $2.00 $2.04 513 690
Feb 14, 2019 $2.06 $2.18 $2.01 $2.03 562 436
Feb 13, 2019 $2.06 $2.10 $2.00 $2.06 506 799
Feb 12, 2019 $2.14 $2.16 $1.96 $2.07 323 511
Feb 11, 2019 $1.98 $2.02 $1.97 $1.99 306 629
Feb 08, 2019 $1.98 $2.05 $1.95 $1.97 254 859
Feb 07, 2019 $2.06 $2.13 $1.94 $2.00 607 815
Feb 06, 2019 $2.27 $2.27 $2.06 $2.06 450 012
Feb 05, 2019 $2.24 $2.37 $2.17 $2.24 596 280
Feb 04, 2019 $2.23 $2.33 $2.18 $2.20 468 005
Feb 01, 2019 $2.35 $2.40 $2.21 $2.24 504 212
Jan 31, 2019 $2.34 $2.45 $2.16 $2.33 646 297
Jan 30, 2019 $2.20 $2.34 $2.01 $2.30 1 384 947
Jan 29, 2019 $1.77 $2.56 $1.73 $2.15 3 222 488
Jan 28, 2019 $1.81 $1.88 $1.72 $1.75 483 995
Jan 25, 2019 $1.77 $1.82 $1.69 $1.78 326 635
Jan 24, 2019 $1.73 $1.83 $1.72 $1.79 157 875
Jan 23, 2019 $1.87 $1.87 $1.71 $1.72 232 320
Jan 22, 2019 $1.86 $1.87 $1.81 $1.85 275 215
Jan 18, 2019 $1.91 $1.91 $1.82 $1.85 231 837
Jan 17, 2019 $1.86 $1.92 $1.83 $1.88 197 565
Jan 16, 2019 $1.83 $1.98 $1.83 $1.87 304 301
Jan 15, 2019 $1.88 $1.89 $1.62 $1.82 413 227
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT